October 06, 2025

What Links TBI and ALS Risk?

Researchers found a time-dependent link between traumatic brain injury and amyotrophic lateral sclerosis, with the highest risk in the 2 years after injury.

Conexiant

October 06, 2025

The Golden Age of Drug Discovery

Sitting down with Insmed’s Tom Heightman, we discuss new technologies for drug discovery and the promise of human genome sequencing data.

The Medicine Maker

October 03, 2025

From Agent Orange to PCBs: Lessons for Care

Air Force reviews cancer risk in missile crews; early analyses show no excess mortality, but exposures to PCBs and benzene prompt vigilance and targeted histories.

KFF Health News

October 02, 2025

Distal vs Shaft Tibia Fractures in Children

Open distal tibia fractures in pediatric patients are more severe than shaft fractures.

Conexiant

October 01, 2025

FDA Data Show Rise During Benadryl Social Media Challenge

TikTok trend resurfaces as diphenhydramine misuse among youth patients remains reported.

Conexiant

September 26, 2025

Old Medicine, New Hope for Speech?

Leucovorin, a folic acid–derived drug, is under study for speech benefits in children with autism.

KFF Health News

September 26, 2025

Could a Simple Blood Test Stratify Myasthenia Gravis?

Findings highlight potential of serum neurofilament light chain as a biomarker for late-onset myasthenia gravis

The Pathologist

September 26, 2025

Robust Efficacy in Regeneron Phase III Autoimmune Trial

Company plans to submit siRNA drug for regulatory approval in 2026

The Medicine Maker

September 23, 2025

Juvenile SLE: Feasibility of Early Glucocorticoid Tapering

Early glucocorticoid tapering in juvenile systemic lupus erythematosus is feasible without added flare risk, though anti-double-stranded DNA positivity signals higher relapse odds.

Conexiant